Cello World Limited IPO Message Board (Page 37)

GMP : 121
Source .. IPOpremium

Big sized IPO. Total OFS, so nothing is going to the company. Promoters Rathods and family are selling their shares. Still holding 91.8% equity after this OFS. A good thing for the company and investors. Financials are good. But not that much against the pricing of the issue of f v of 5. Pricing we may call at higher-end. Not to expect more from promoters. Minimum 10% positive listing is good on an investment of 10 days.
Anchor book is good with combination of different levels. However, GMP is ruling below 20%. Not bad at the moment. Next week's market is very important, specially opening and closing. Listing gains may come down also and go up with market condition upto the closing of IPO. There are many better companies in the market for house hold items but Cello is not a bad NAME.
To decide for medium to long-term investment depends after listing and market conditions.

I am expecting RHP filling For Motisons or Protean tomorrow
And can also expect some other Primary Market Actionn

Good Luck to those who Apply CELLO ...🙏

Just Went through Anchor Book
It is Absolutely Good
All Top quality Mutual Funds , FII's coming in

Saw Reliance General Insurance , CLSA ,
Florida coming after a Long holiday
Brinker Capital coming in India Maybe for the 1st time

Overall A strong one

Can expect Good listing gains here and also Post Listing action

GMP : 122-124 ( New High )

Protean , ASK Automotive to be announced soon

GMP : 119-122

Company is in business of consumer houseware, consumer glassware, writing instruments, moulded plastic furniture. Company has 13 operational manufacturing facilities while 1 is under construction. Company does it’s business through 8 units of which 1 WimPlast is BSE listed entity wherein Cello holds 55% stake.
Focussed hands on 2nd and 3rd generation promoters with 30/40+ years of industry experience.
Around 92% of sales are domestic while 8% are exports.
In 22-23, YoY sales growth of 32%, EBITDA growth of 25% and PBT growth of 28.7%
Q1FY24 over Q1FY23, sales growth of 8.7%, EBITDA growth of 26% and PBT growth of 31%      
EBITDA margins for 21-22 at 25.7%, for 22-23 at 24.3% and for Q1FY24 at 27%.
Material cost as % of sales for 21-22 and 22-23 was 50% while for Q1FY24 was 47%
Decent cash flow, PBT for 39 months (ending Q1FY24) was Rs 1035 cr while CFOB4T for the same period was Rs 960 cr.
PE and VC were issued preference shares in Oct-Dec ’22 which were converted to equity shares @ Rs 276/- per share.
Full OFS, post IPO promoter equity will still be high @ 91.8%
As on 30-Jun-23, company had 5502 employees across 10 legal entities. As per EPFO, company deposited PF of 2959 employees for Sep-22 and 3489 employees for Sep-23.
Company does not have high dependence on a group of suppliers or customers.
Forex gain income was Rs 2 cr in 22-23 against Rs 2.6 cr in 21-22.
Other income, apart from forex gain, consists of interest on deposits & financial assets, gain on investments measured through P&L and gain on sale of subsidiary.
Other expenses for 22-23 at Rs 323 cr were 50% higher than Rs 215 cr for 21-22. Increase in advertisement expenditure, freight outward, job work charges, legal & professional fees, rent, royalty, sales commission, sales promotion & conference charges, selling & distribution expense, and loss on conversion of CCPS were main line items.
As on 30-Jun-23, plant & machinery of Rs 1.6 cr is work in progress for more than 1 year.
Investments of company include 3.5 lacs units of Mindspace REIT and 1.5 lac units of Brookfield REIT over and above investments in SBI Arbitrage fund, SBI Banking/PSU fund and ICICI Long Short Fund (mutual fund schemes).
As on 30-Jun-23, receivables were Rs 529 cr against which company has made bad debt provision of Rs 6.4 cr.
Out of the recievables of Rs 529 cr, Rs 324 cr were not due, Rs 186 cr were overdue less than 6 months while Rs 19 cr were overdue for more than 6 months.
Inventory turnover ratio improved from 1.99 in 21-22 to 2.22 in 22-23 while receivables turnover ratio improved from 3.5 in 21-22 to 4.1 in 22-23
As on 30-jun-23, promoters & related parties have given Rs 290 cr loan to the company. Appears that this is interest free and unsecured.
Strong anchor book, participation by 39 institutions for allotment of Rs 570 cr.

पहले GMP हाई लेके जायेंगे फिर 5-10 डाउन करके डराने की कोशिश करेंगे की GMP crashed ..😝😝

Aap 🔵✈️ me nahi dare, ye to bear me bhi safe bid hai.

AMITABH BACCHAN is lucky for everyone

Big B brand ambassador of Kalyan jewellers ipo to take 2 years to crossed ipo price.🤫

⚓ 1

⚓ 3

Final

Anchor list to dhamakedar hai ll

Big B is the brand ambassador of cello?
Just saw ad.
First Kalyan jewellers
Than
Bikaji food
And now
Cello world

Exactly Right
Ha Ha Ha....

​@harit I don't think Amitji the great might not be eating Bikaji Namkeen at home and not using Cello products for daily use at home. His profession, so paid for that.
**ALL THAT GLITTER IS NOT GOLD**, we know.

Forget he is using all these at home or not, the shares may in medium to long-term move in that way.
As far as listing gain is there, it should be there. Market may improve in coming days, I pray.

Anchor list?

GMP
122/124
TOUCHING NEW HIGH

GMP 115 (all time high)
Good going
Sources -ipo premium

118🚀

Recommendation: To apply 327 lots for long term.

Live 🚀 GMP 109 ⬆️⬆️

Almost applying every ipo from last 6-7 years.
Par kabhi return or equity (ROE) 134 itna high dekha nahi mainline ipo main..
Mere andaz se koi bhi ipo return on equity itna high nahi dekha...
Old-members, plz replay on this if I am wrong on right....

Check TataComm,
Its because it has very low shareholder’s equity

How many times it will be subscribe in retail catagory (app wise)....any expert please threw your expectations....

Not more than 3x-5x, a broad range

Thanks @Ujwal ji...

Buyer 104/-

Thanks...if alloted one can keep for Long term

Employees have Rs. 61 discount. Will this stock list in discount?

No relation, employee quota normally has 10% discount